Log In
Print this Print this

SLI 1047

  Manage Alerts
Collapse Summary General Information
Company SLIL Biomedical Corp.
DescriptionPolyamine analog that depletes cells of polyamines
Molecular Target Not available
Mechanism of ActionNA
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationLymphoma
Indication DetailsTreat AIDS-related lymphoma (ARL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today